The Covid-19 treatment from Pfizer Inc. has become the leading pandemic pill prescribed in the U.S., as supplies have improved and its availability at pharmacies widened.
Pfizer’s antiviral drug, called Paxlovid, totaled more than 412,000 prescriptions through May 6, compared with about 110,000 prescriptions of molnupiravir, an antiviral from Merck & Co. and Ridgeback Biotherapeutics LP, according to drug-data firm Iqvia Holdings Inc.
